vs

Side-by-side financial comparison of Marygold Companies, Inc. (MGLD) and SS Innovations International, Inc. (SSII). Click either name above to swap in a different company.

SS Innovations International, Inc. is the larger business by last-quarter revenue ($14.5M vs $7.6M, roughly 1.9× Marygold Companies, Inc.). Marygold Companies, Inc. runs the higher net margin — -7.5% vs -17.0%, a 9.5% gap on every dollar of revenue. On growth, SS Innovations International, Inc. posted the faster year-over-year revenue change (79.1% vs -4.5%). Over the past eight quarters, SS Innovations International, Inc.'s revenue compounded faster (99.9% CAGR vs -1.5%).

Marygold Companies, Inc. is a U.S.-headquartered diversified holding company that operates across three core segments: financial services, specialty manufacturing, and consumer goods. It primarily caters to North American markets, driving long-term value growth via strategic investment in, and operational optimization of, its portfolio of subsidiary entities.

SS Innovations International, Inc. is a global medical technology enterprise specializing in the research, development and manufacturing of innovative surgical robotic systems. It provides high-precision, accessible robotic platforms for minimally invasive surgery, catering to healthcare facilities across multiple regions to boost surgical outcomes and cut procedural burdens.

MGLD vs SSII — Head-to-Head

Bigger by revenue
SSII
SSII
1.9× larger
SSII
$14.5M
$7.6M
MGLD
Growing faster (revenue YoY)
SSII
SSII
+83.6% gap
SSII
79.1%
-4.5%
MGLD
Higher net margin
MGLD
MGLD
9.5% more per $
MGLD
-7.5%
-17.0%
SSII
Faster 2-yr revenue CAGR
SSII
SSII
Annualised
SSII
99.9%
-1.5%
MGLD

Income Statement — Q2 FY2026 vs Q4 FY2025

Metric
MGLD
MGLD
SSII
SSII
Revenue
$7.6M
$14.5M
Net Profit
$-576.0K
$-2.5M
Gross Margin
74.0%
43.9%
Operating Margin
-8.3%
-3.7%
Net Margin
-7.5%
-17.0%
Revenue YoY
-4.5%
79.1%
Net Profit YoY
67.0%
-28.5%
EPS (diluted)
$-0.01
$-0.01

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MGLD
MGLD
SSII
SSII
Q4 25
$7.6M
$14.5M
Q3 25
$7.0M
$12.8M
Q2 25
$7.2M
$10.0M
Q1 25
$7.0M
$5.1M
Q4 24
$8.0M
$8.1M
Q3 24
$7.9M
$4.4M
Q2 24
$8.3M
$4.5M
Q1 24
$7.9M
$3.6M
Net Profit
MGLD
MGLD
SSII
SSII
Q4 25
$-576.0K
$-2.5M
Q3 25
$-356.0K
$-3.7M
Q2 25
$-1.5M
$-256.7K
Q1 25
$-1.0M
$-5.7M
Q4 24
$-1.7M
$-1.9M
Q3 24
$-1.6M
$-3.2M
Q2 24
$-1.9M
$-4.1M
Q1 24
$-529.0K
$-9.8M
Gross Margin
MGLD
MGLD
SSII
SSII
Q4 25
74.0%
43.9%
Q3 25
77.0%
48.1%
Q2 25
67.8%
59.1%
Q1 25
75.0%
21.2%
Q4 24
74.1%
48.9%
Q3 24
73.1%
52.8%
Q2 24
72.5%
31.9%
Q1 24
70.5%
20.0%
Operating Margin
MGLD
MGLD
SSII
SSII
Q4 25
-8.3%
-3.7%
Q3 25
-18.2%
-14.3%
Q2 25
-16.5%
1.0%
Q1 25
-21.4%
-115.6%
Q4 24
-22.8%
-22.7%
Q3 24
-27.4%
-73.1%
Q2 24
-33.3%
-90.9%
Q1 24
-18.7%
-270.3%
Net Margin
MGLD
MGLD
SSII
SSII
Q4 25
-7.5%
-17.0%
Q3 25
-5.1%
-29.0%
Q2 25
-20.4%
-2.6%
Q1 25
-14.4%
-111.0%
Q4 24
-21.8%
-23.7%
Q3 24
-20.1%
-74.0%
Q2 24
-22.5%
-91.8%
Q1 24
-6.7%
-270.5%
EPS (diluted)
MGLD
MGLD
SSII
SSII
Q4 25
$-0.01
$-0.01
Q3 25
$-0.01
$-0.02
Q2 25
$-0.04
$0.00
Q1 25
$-0.02
$-0.03
Q4 24
$-0.04
$-0.01
Q3 24
$-0.04
$-0.02
Q2 24
$-0.05
$-0.02
Q1 24
$-0.01
$-0.06

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MGLD
MGLD
SSII
SSII
Cash + ST InvestmentsLiquidity on hand
$11.6M
$3.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$22.7M
$38.2M
Total Assets
$27.8M
$74.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MGLD
MGLD
SSII
SSII
Q4 25
$11.6M
$3.2M
Q3 25
$12.5M
$5.7M
Q2 25
$12.8M
$11.4M
Q1 25
$15.6M
$15.9M
Q4 24
$14.9M
$466.5K
Q3 24
$17.5M
$220.4K
Q2 24
$15.0M
$608.2K
Q1 24
$16.1M
$948.1K
Stockholders' Equity
MGLD
MGLD
SSII
SSII
Q4 25
$22.7M
$38.2M
Q3 25
$22.9M
$39.6M
Q2 25
$23.0M
$42.0M
Q1 25
$24.3M
$40.6M
Q4 24
$23.4M
$13.5M
Q3 24
$25.5M
$13.7M
Q2 24
$26.6M
$14.8M
Q1 24
$28.4M
$16.7M
Total Assets
MGLD
MGLD
SSII
SSII
Q4 25
$27.8M
$74.2M
Q3 25
$28.4M
$69.6M
Q2 25
$30.4M
$70.0M
Q1 25
$33.5M
$63.5M
Q4 24
$33.0M
$42.4M
Q3 24
$35.9M
$39.0M
Q2 24
$32.9M
$35.7M
Q1 24
$33.7M
$35.2M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MGLD
MGLD
SSII
SSII
Operating Cash FlowLast quarter
$-908.0K
$-1.5M
Free Cash FlowOCF − Capex
$-3.2M
FCF MarginFCF / Revenue
-22.3%
Capex IntensityCapex / Revenue
0.0%
11.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-22.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MGLD
MGLD
SSII
SSII
Q4 25
$-908.0K
$-1.5M
Q3 25
$-533.0K
$-7.5M
Q2 25
$-3.3M
$-3.5M
Q1 25
$-1.2M
$-6.1M
Q4 24
$-770.0K
$-3.3M
Q3 24
$-893.0K
$-2.5M
Q2 24
$-1.9M
$-1.0M
Q1 24
$-658.0K
$-2.7M
Free Cash Flow
MGLD
MGLD
SSII
SSII
Q4 25
$-3.2M
Q3 25
$-562.0K
$-8.2M
Q2 25
$-3.4M
$-3.8M
Q1 25
$-7.0M
Q4 24
$-776.0K
$-3.4M
Q3 24
$-940.0K
$-4.2M
Q2 24
$-2.0M
$-3.1M
Q1 24
$-2.8M
FCF Margin
MGLD
MGLD
SSII
SSII
Q4 25
-22.3%
Q3 25
-8.1%
-64.1%
Q2 25
-46.8%
-37.7%
Q1 25
-136.2%
Q4 24
-9.7%
-41.7%
Q3 24
-11.9%
-96.9%
Q2 24
-23.8%
-69.5%
Q1 24
-76.9%
Capex Intensity
MGLD
MGLD
SSII
SSII
Q4 25
0.0%
11.8%
Q3 25
0.4%
5.9%
Q2 25
0.7%
3.2%
Q1 25
0.0%
17.0%
Q4 24
0.1%
1.5%
Q3 24
0.6%
38.8%
Q2 24
0.7%
46.8%
Q1 24
0.0%
3.5%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MGLD
MGLD

Fund Management Related Party$4.6M60%
Food Products$1.7M22%
Beauty Products$1.2M15%
Other$268.0K4%

SSII
SSII

System Sales$13.4M92%
Other$1.2M8%

Related Comparisons